Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 388, 347-356
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Opening of the Blood-Brain Barrier before Cerebral Pathology in Mild HyperhomocysteinemiaPLOS ONE, 2013
- Elevated Homocysteine by Levodopa Is Detrimental to Neurogenesis in Parkinsonian ModelPLOS ONE, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Why have total cholesterol levels declined in most developed countries?BMC Public Health, 2011
- Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in MicePLOS ONE, 2010
- Influence of Hypercholesterolemia and Hypertension on the Integrity of the Blood–Brain Barrier in RatsInternational Journal of Neuroscience, 2009
- Constitutive Ret Activity in Knock-In Multiple Endocrine Neoplasia Type B Mice Induces Profound Elevation of Brain Dopamine Concentration via Enhanced Synthesis and Increases the Number of TH-Positive Cells in the Substantia NigraJournal of Neuroscience, 2007
- Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphinePharmacology Biochemistry and Behavior, 2006
- Effects of Homocysteine on the Dopaminergic System and Behavior in RodentsNeuroToxicology, 2005
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988